gemcitabine has been researched along with Cardiotoxicity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kume, S; Kurokawa, T; Liu, G; Liu, Y; Morishima, M; Ono, K; Osanai, H; Wang, P; Wei, M; Yoshimura, K; Zheng, M; Zhu, X | 1 |
| Bao, YL; Chen, JW; Du, C; Gu, AH; Gu, LF; Ji, Y; Jiang, QQ; Shan, TK; Sun, CQ; Wang, H; Wang, LS; Wang, QM; Wang, SB; Wei, TW; Xie, LP; Yang, TT; Zhou, LH | 1 |
| Adam, J; Assi, T; Baldi, GG; Barisella, M; Ben-Ami, E; Benjamin, RS; Blay, JY; Casali, PG; Czarnecka, AM; Desar, I; Duffaud, F; Dufresne, A; Fedenko, A; Ferraro, R; Frezza, AM; Gelderblom, H; Gounder, M; Gronchi, A; Hornick, JL; Jones, RL; Kawai, A; Le Cesne, A; Lo Vullo, S; Maki, RG; Mariani, L; Meurgey, A; Mir, O; Noguchi, E; Pantaleo, MA; Ravi, V; Sbaraglia, M; Schuetze, S; Siontis, B; Stacchiotti, S; Teterycz, P; Thornton, K; Vincenzi, B; Wagner, AJ; Yonemori, K | 1 |
| Gürses, E; Kemal, HS; Kültürsay, H; Özbay, B; Şimşek, E | 1 |
| Davlouros, P; Hahalis, G; Koniari, I; Kounis, NG; Plotas, P; Soufras, GD; Tsigkas, G | 1 |
| Boyella, R; Gottesman, S; Juneman, E; Khan, MF | 1 |
1 review(s) available for gemcitabine and Cardiotoxicity
| Article | Year |
|---|---|
Gemcitabine-induced cardiomyopathy: a case report and review of the literature.
Topics: Antimetabolites, Antineoplastic; Cardiomyopathies; Cardiotoxicity; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Ultrasonography; Ventricular Dysfunction, Left | 2014 |
5 other study(ies) available for gemcitabine and Cardiotoxicity
| Article | Year |
|---|---|
Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel.
Topics: Animals; Antineoplastic Agents; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cardiotoxicity; Delayed Rectifier Potassium Channels; Down-Regulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gemcitabine; HEK293 Cells; Humans; Lung Neoplasms; Rats | 2023 |
SIRT3-dependent mitochondrial redox homeostasis mitigates CHK1 inhibition combined with gemcitabine treatment induced cardiotoxicity in hiPSC-CMs and mice.
Topics: Animals; Cardiotoxicity; Checkpoint Kinase 1; Gemcitabine; Homeostasis; Induced Pluripotent Stem Cells; Mice; Mitochondria; Myocytes, Cardiac; Oxidation-Reduction; Sirtuin 3 | 2023 |
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Deoxycytidine; Female; Gemcitabine; Heart Neoplasms; Humans; Indazoles; Male; Middle Aged; Prognosis; Progression-Free Survival; Proto-Oncogene Proteins c-mdm2; Pyrimidines; Sarcoma; Sulfonamides; Treatment Outcome; Tunica Intima | 2020 |
Takotsubo syndrome early after treatment due to non cardiotoxic chemotherapy agents.
Topics: Aged; Antineoplastic Agents; Carcinoma; Cardiotoxicity; Deoxycytidine; Echocardiography; Electrocardiography; Female; Gemcitabine; Humans; Kidney Neoplasms; Myocardial Infarction; Takotsubo Cardiomyopathy; Vinorelbine | 2021 |
Emergence, development, and future of cardio-oncology in China: cardiohypersensitivity, cardiotoxicity and the Kounis syndrome.
Topics: Afatinib; Carcinoma, Squamous Cell; Cardiotoxicity; China; Cisplatin; Coronary Artery Disease; Deoxycytidine; Gemcitabine; Humans; Kounis Syndrome; Male; Medical Oncology; Middle Aged | 2019 |